[This review was originally posted at the Nieman Journalism Lab Purchase Lipitor, on March 18, 2011.]
First reactions to The Times' paid-content plans: Yesterday The New York Times rolled out the online paid-content plans they've been talking about for a little more than a year. You get 20 articles a month for free (besides the ones you get to through Google and social media), and after that it's going to cost you anywhere from $15 to $35 per four weeks, depending on what devices you want to access it on. Print subscribers will get it all for free. (Yup, as the Lab's Josh Benton and Forbes' Jeff Bercovici pointed out, that means there are print plans with online access that are cheaper than the online-only ones.) Subscriptions will sold, Lipitor results, among other places, in Apple's iTunes store. Here's The Times' letter to readers and news article, as well as the Lab's glimpse at the paywall and a good paidContent FAQ.
Now for the reaction and analysis: If you only have time for a few pieces, make them Ken Doctor, Steve Outing, and Felix Salmon, Purchase Lipitor. If you want a quick sampler platter of opinions, you can't do any better than the Lab's roundup of 11 experts' thoughts.
There was no consensus of initial opinion about the plan; many supporters spoke up quickly, including The Times' own media critic, David Carr, purchase Lipitor, and The Daily Beast's Howard Kurtz. Poynter newspaper analyst Rick Edmonds broke down the ways it met all the initial criteria of a sound paywall plan, and British j-prof Paul Bradshaw called it "the most mature, intelligent, and commercially sensible paywall model yet," praising its respect for distribution and online engagement. At The Columbia Journalism Review, Lipitor over the counter, Ryan Chittum said it looked good, and Lauren Kirchner issued a rejoinder to the "information wants to be free" crowd. Purchase Lipitor, The Times' detractors were quick to speak up, too. Media analyst Steve Outing laid out most of the basic objections: The prices are too high, people will turn away when they hit the 20-article limit, and the differentiation by device doesn't make sense. (TechCrunch's Erick Schonfeld harped on the latter point, too.) Reuters' Felix Salmon chimed in by saying that the price point is high enough that a lot of regular readers won't subscribe (meaning the plan won't bring in much revenue anyway), and that the Times is discouraging use of its iPad.
At BoingBoing, Lipitor forum, Cory Doctorow said most users will find the metering system frustrating, leading them to find other ways to read The Times or just not read it at all. Techdirt's Mike Masnick made a similar point, adding that The Times isn't adding any value with the plan. That was tech pioneer Dave Winer's main beef: "They're not offering anything to readers other than the Times' survival, and they're not even explicit about that."
Plenty of commentary didn't fall into either the "pro" or "con" camp, of course, Purchase Lipitor. Here at the Lab, Ken Doctor provided the definitive economic analysis of the plan, breaking down the seven tests it must pass to be successful. Discount Lipitor, Then there was the issue of getting around the paywall (or, as Doctor more accurately called it, the fence): Business Insider told us how to do it via Google, and TechCrunch pontificated on the social media loophole that will develop in addition to the current Google one. Media consultant Steve Yelvington downplayed that factor: "It's not supposed to be a bank vault, people. It's a polite request for payment."
Another obvious next question is whether this could be applied to other news organizations. Purchase Lipitor, Meranda Watling of 10,000 Words compared the plan with those of The Wall Street Journal and Newsday, but Amy Gahran of the Knight Digital Media Center gave other newspapers a stern "don't try this at home."
Breaking down an old debate at SXSW: Just as they do every March, geeks descended on Austin, Texas, last weekend for the South by Southwest Interactive Festival, and as usual, there was plenty of journalism-related stuff to chew on, even for those of us who didn't attend. The session that seemed to get the most traction online was NYU professor Jay Rosen's psychological analysis of the tension between bloggers and journalists — which is perhaps a bit surprising for a battle that Rosen himself declared "over" six years ago.
Rosen's whole talk is worth a read, online buy Lipitor without a prescription, but here's the gist of it: For journalists, bloggers are the idealized face of all the ideological and professional stresses they deal with, and for bloggers, the conflict helps keep them on the "outside" of the system, allowing them to maintain their innocence and rhetorical power. Snarkmarket's Matt Thompson and Tim Carmody liveblogged their analysis of the talk, and The Guardian summarized it. Lipitor pics, Michele McLellan of the Knight Digital Media Center ripped blogger-hating journalists for fighting an outdated war, but Melissa Bell of the Washington Post called Rosen's characterization of objectivity misleading.
There were plenty of other panels worth reading about, too, including NYU prof Clay Shirky's timely talk on social media and revolution, in which he said that governments routinely overestimate our access to information and underestimate our access to each other, Purchase Lipitor. (The Guardian had a short summary, and Poynter's Julie Moos put together a blow-by-blow in Storify.)
There were also a couple of panels on the value of gaming, particularly in news, as well as sessions on building trust online, using social media to evade censorship, the future of public media, iPad news apps, is Lipitor safe, and SEO tips from Google and Bing. Poynter's Steve Myers pulled together a dozen journalists for an overview of the conference in terms of building community, and an Economist blogger tied this year's SXSW to last year's with a sharp post questioning the story as the basic unit of journalism.
A critical eye on NPR's antagonists: The damage to NPR from James O'Keefe's hidden-camera exposé was already done last week, but the scrutiny of the tape itself didn't begin in earnest until the weekend — kicked off by, of all places, Glenn Beck's website, Lipitor from canada, The Blaze. (Time's James Poniewozik's breakdown is also worth a read.) The site's skepticism of the video's editing was picked up by NPR media reporter David Folkenflik, who examined the issue in a broadcast report. NPR's spokeswoman called the video Purchase Lipitor, "inappropriately edited," but said the executive in the tape had still made "egregious statements."
Whatever O'Keefe's ethics, Poynter's Steve Myers said, there's plenty he understands about today's media environment that we can learn from: Investigative journalism is in demand, raw media communicates "reality," and soundbites and reducing opponents' logic to absurdities trump context in the online media world.
The change in leadership at NPR prompted others to look at the health and direction of the organization overall: The New York Times' David Carr examined NPR's success in light of the public-funding argument, and Poynter's Mallary Jean Tenore laid out the four biggest challenges for NPR's next CEO. The Lab's Nikki Usher looked overseas for public media comparisons, and The Columbia Journalism Review talked to Jonathan Holmes of the Australian Broadcasting Corporation about the public media situation there.
A snapshot of the state of journalism: Pew's Project for Excellence in Journalism released its annual State of the Media report this week, summarizing last year as a good one for journalism. The big headline that most media outlets took away from the study was that for the first time, online news consumption has surpassed newspaper use. There were plenty of other nuggets from the study, though, covering a variety of news media.
The study outlined the state of the newspaper industry, touching on all the major themes from circulation to advertising to digital paid-content efforts, Purchase Lipitor. One of the authors of that part of the study, Poynter's Rick Edmonds, Lipitor overnight, summarized the trends he found interesting.
It also included a look at the economics of startup community journalism, with discussion of nonprofits, ad-based sites, and the Patch model. (Author Michele McLellan summarized her main points here.) The researchers also reported on a survey on mobile news use, and Amy Gahran of the Knight Digital Media Center and Damon Kiesow of Poynter highlighted some of the opportunities for news organizations in its results.
A couple of other tidbits from the study: Search Engine Land's Vanessa Fox focused on revenue from advertising, subscriptions, Lipitor alternatives, and mobile apps, and j-prof Alfred Hermida pointed out the difference between the news agendas of Twitter, blogs and the mainstream media.
Twitter tells developers to hold off: Twitter made waves in the tech world late last week when they posted a note Purchase Lipitor, telling developers not to develop any more Twitter clients, saying they'd like to do it themselves, ostensibly for consistency's sake. (Mashable has a great explanation of the issue.) Most of the initial reaction was not enthusiastic: Salon's Dan Gillmor said the note was a reminder that we need other options for our online platforms that aren't controlled by a single company, and Dave Winer said it reinforces the fact the open web is the best place to develop.
Mathew Ingram of GigaOM and developer Fred Oliveira both urged Twitter to rethink its decision, noting that third-party apps like Tweetdeck and Tweetie spurred much of Twitter's initial growth. Lipitor without prescription, And ReadWriteWeb's Marshall Kirkpatrick saw this as a hint at where Twitter is headed culturally: "If you thought Twitter was a place for outlaws, for free thinkers, for innovators - you need to tuck in your shirt, cut your hair and get a clue."
Others, however, defended Twitter: Social media marketer Jesse Stay said he wishes Twitter had done this a while ago, and developer Rob Diana argued that Twitter has finally given developers a solid sense of direction while still giving them some freedom.
Reading roundup: A few notes to digest while your bracket goes up in flames:
— The big news story of the past week has been the earthquake, tsunami and their aftermath in Japan, Lipitor online cod. There wasn't a whole lot written about it from a media perspective, but there were a couple of insightful posts, Purchase Lipitor. Doc Searls looked at coverage and concluded that the web is subsuming TV and radio, and Jeff Jarvis asked for separate Twitter hashtags for breaking news event witnesses.
— A few leftover AOL/Huffington Post items: GigaOM's Mathew Ingram looked at why AOL is desperate for some successful content initiatives, Arianna Huffington talked SEO, TechCrunch broke down the journalism/churnalism tension at AOL, and The New York Times' Bill Keller issued a non-apology followup to his Huffington-bashing essay last week.
— A couple of stray items from the commenting discussion of the last couple of weeks: Via O'Reilly Radar, Effects of Lipitor, statistics showing the integration of Facebook Comments led to fewer comments at TechCrunch, and a defense of anonymous commenting from Paul O'Flaherty.
— Finally, the Lab has the transcript of an interesting talk Northwestern prof Pablo Boczkowski gave about the gap between what news consumers want and what they get, with a thoughtful response from the Lab's Josh Benton. Enjoy.
Similar posts: Diflucan Cost. Diflucan For Sale. Armour Price. Cipro alternatives. Armour blogs. Diflucan duration.
Trackbacks from: Purchase Lipitor. Purchase Lipitor. Purchase Lipitor. Lipitor results. Lipitor street price. Generic Lipitor.
[This review was originally posted at the Nieman Journalism Lab Bactrim No Rx, on Feb. 25, 2011.]
The short, happy-ish life of TBD: Just six months after it launched and two weeks after a reorganization was announced, the Washington, D.C., local news site was effectively shuttered this week, where can i buy cheapest Bactrim online, when its corporate parent, Allbritton Communications (it's owned by Robert Allbritton and includes Politico), cut all of its jobs, leaving only an arts and entertainment operation within the website of Allbritton's WJLA-TV.
TBD had been seen many as a bellwether in online-only local news, After Bactrim, as Poynter's Mallary Jean Tenore documented in her historical roundup of links about the site, so it was quite a shock and a disappointment to many future-of-newsies that it was closed so quickly. The response — aptly compiled by TBDer Jeff Sonderman — was largely sympathetic to TBD's staff (former TBD manager Jim Brady even wrote a pitch to prospective employers on behalf of the newly laid off community engagement team). Many observers on Twitter (and Terry Heaton on his blog) pointed squarely at Allbritton for the site's demise, with The Batavian's Howard Owens drawing out a short, thoughtful lesson: "Legacy managers will nearly always sabotage innovation. Wall of separation necessary between innovators and legacy."
Blogger Mike Clark pointed out that TBD's traffic was beating each of the other D.C. TV news sites and growing as well, Bactrim No Rx. The Washington Post reported that while traffic wasn't a problem, Bactrim blogs, turning it into revenue was — though the fact that TBD's ads were handled by WJLA staffers might have contributed to that.
Mallary Jean Tenore wrote an insightful article talking to some TBD folks about whether their company gave them a chance to fail. Lehigh j-prof Jeremy Littau was unequivocal on the subject: "Some of us have been talking today on Twitter about whether TBD failed. Nonsense. TBD wasn’t given enough time to fail."
While CUNY j-prof Jeff Jarvis lamented Bactrim No Rx, that "TBD will be painted as a failure of local news online when it's a failure of its company, nothing more," others saw some larger implications for other online local news projects. Media analyst Alan Mutter concluded that TBD's plight is "further evidence that hyperlocal journalism is more hype than hope for the news business, Order Bactrim from United States pharmacy, " and Poynter's Rick Edmonds gave six business lessons for similar projects from TBD's struggles. Journal Register Co. CEO John Paton ripped Edmonds' analysis, arguing that Allbritton "can’t pretend to have seriously tried the hyperlocal business space after a six-month experiment it derailed half-way in."
Applying Apple's new rules: Publishers' consternation over Apple's new subscription plan for mobile devices continued this week, with Frederic Filloux at Monday Note laying out many publishers' frustrations with Apple's proposal. The New York Times' David Carr and The Guardian's Josh Halliday both covered publishers' Apple subscription conundrum, and one expert told Carr, Bactrim over the counter, "If you are a publisher, it puts things into a tailspin: The business model you have been working with for many years just lost 30 percent off the top."
At paidContent, James McQuivey made the case for a lower revenue share for Apple, and Dan Gillmor wondered whether publishers will stand up to Apple. The company may also be facing scrutiny from the U.S, Bactrim No Rx. Justice Department and Federal Trade Commission for possible antitrust violations, Buy Bactrim without a prescription, The Wall Street Journal reported.
The fresh issue regarding Apple's subscription policy this week, though, was the distinction between publishing apps and more service-oriented apps. The topic came to the fore when the folks from Readability, an app that allows users to read articles in an advertising-free environment, wrote an open letter ripping Apple for rejecting their app, buying Bactrim online over the counter, saying their new policy "smacks of greed." Ars Technica's Chris Foresman and Apple blogger John Gruber noted, though, that Readability's 30%-off-the-top business model is a lot like Apple's.
Then Apple's Steve Jobs sent a short, cryptic email to a developer saying that Apple's new policy applies only to publishing apps, Rx free Bactrim, not service apps. Bactrim No Rx, This, of course, raised the question, in TechCrunch's words, "What's a publishing app?" That's a very complex question, and as Instapaper founder Marco Arment wrote, one that will be difficult for Apple to answer consistently. Arment also briefly noted that Jobs' statement seems to contradict the language of Apple's new guidelines.
Giving voice to new sources of news: This month's Carnival of Journalism, posted late last week, focused on ways to increase the number of news sources. It's a broad question, and it drew a broad variety of answers, Bactrim schedule, which were ably summarized by Courtney Shove. I'm not going to try to duplicate her work here, but I do want to highlight a few of the themes that showed up.
David Cohn, the Carnival's organizer, gave a great big-picture perspective to the issue, putting it in the context of power and the web. Kim Bui and Dan Fenster defended the community-driven vision for news, with Bui calling journalists to go further: "Let’s admit it, we’ve never trusted the public." There were several calls for journalists to include more underrepresented voices, with reports and ideas like a refugee news initiative, digital news bus, youth journalism projects, and initiatives for youth in foreign-language families, Bactrim No Rx.
The J-Lab's Jan Schaffer gave 10 good ideas to the cause, and Drury j-prof Jonathan Groves and Gannett's Ryan Sholin shared their ideas for local citizen news projects, Bactrim australia, uk, us, usa, while TheUpTake's Jason Barnett endorsed a new citizen-journalism app called iBreakNews.
Three bloggers, however, objected to the Carnival's premise in the first place. Daniel Bachhuber of CUNY argued that improving journalism doesn't necessarily mean adding more sources, recommending instead that "Instead of increasing the number of news sources, we should focus on producing durable data and the equivalent tools for remixing it." Lauren Rabaino warned against news oversaturation, order Bactrim no prescription, and the University of Colorado's Steve Outing said that more than new sources, we need better filters and hubs for them.
Blogging's continued evolution: The "blogging is dead" argument has popped up from time to time, and it was revived again this week in the form of a New York Times story about how young people are leaving blogs for social networking sites like Facebook and Twitter. Bactrim No Rx, Several people countered the argument, led by GigaOM's Mathew Ingram, who said that blogging isn't declining, but is instead evolving into more of a continuum that includes microblogging services like Twitter, traditional blog formats like Wordpress, and the hybrid that is Tumblr. He and Wordpress founding developer Matt Mullenweg shared the same view — that "people of all ages are becoming more and more comfortable publishing online," no matter the form.
Scott Rosenberg, who's written a history of blogging, looked at statistics to make the point, noting that 14% of online adults keep a blog, buy Bactrim online no prescription, a number he called astounding, even if it starts to decline. "As the online population becomes closer to universal, that is an extraordinary thing: One in ten people writing in public. Our civilization has never seen anything like it." In addition, Bactrim treatment, Reuters' Anthony DeRosa argued that longer-form blogging has always been a pursuit of older Internet users.
Reading roundup: I've got a few ongoing stories to update you on, and a sampling of an unusually rich week in thoughtful pieces.
— A couple of sites took a peek at Gawker's traffic statistics to try to determine the effectiveness of its recent redesign, Bactrim No Rx. TechCrunch saw an ugly picture; Business Insider was cautiously optimistic based on the same data. Gawker disputed TechCrunch's numbers, and Terry Heaton tried to sort through the claims.
— A couple of Middle East/North Africa protest notes: The New York Times told us about the response to Egypt's Internet blackout and the role of mobile technology in documenting the protests, is Bactrim safe. And Amy Gahran of the Knight Digital Media Center gave some lessons from the incredible Twitter journalism of NPR's Andy Carvin.
— The Daily is coming to Android tablets Bactrim No Rx, this spring, and its free trial run has been extended beyond the initial two weeks.
— Matt DeRienzo of the Journal Register Co. wrote about an intriguing idea for a news org/j-school merger.
— Alan Mutter made the case for ending federal funding for public journalism.
— At 10,000 Words, Lauren Rabaino had some awesome things news organizations can learn from tech startups, including thinking of news as software and embracing transparency.
— And here at the Lab, Northwestern prof Pablo Boczkowski gave some quick thoughts on how we tend to associate online news with work, and what that means. He sheds some light about an under-considered aspect of news — the social environments in which we consume it.
Similar posts: Retin A No Rx. Flagyl No Rx. Armour For Sale. Purchase Cipro online no prescription. Synthroid class. Tramadol pharmacy.
Trackbacks from: Bactrim No Rx. Bactrim No Rx. Bactrim No Rx. Bactrim coupon. Bactrim from canada. Online Bactrim without a prescription.
[This review was originally posted at the Nieman Journalism Lab Synthroid For Sale, on Dec. 3, 2010.]
We're covering two weeks instead of the usual one in this review, so there's a ton to pack in here. I'll try to zip through it a little more quickly than usual.
What to make of WikiLeaks: WikiLeaks made its third big document drop since this summer this week, releasing about 250,000 confidential diplomatic cables. Here's coverage by The New York Times, Synthroid duration, The Guardian, Der Spiegel, and a roundup by The Columbia Journalism Review. Time talked to WikiLeaks' Julian Assange about the leak, and Forbes published an interview and long piece about Assange's next target — corporate America, Synthroid For Sale.
As for the leak itself, The Guardian detailed the documents' path from the alleged leaker, U.S. soldier Bradley Manning, to Assange, to a Guardian reporter. Yahoo's Michael Calderone looked at The Times' editorial process with the cables, purchase Synthroid for sale, including the revelation that they got them from The Guardian, not WikiLeaks. The Wall Street Journal and CNN both declined to sign agreements with WikiLeaks to see the documents in advance, and The Journal examined news orgs' decisions on whether or not to publish. The Times explained its own publishing decision, then (quite eloquently) responded to readers' objections. Synthroid For Sale, The reaction against WikiLeaks was quicker and harsher than those following each of its last two leaks. Before the documents were released, its site was hacked, the U.S. Purchase Synthroid online no prescription, and British governments issued pre-emptive condemnations, and senators called for WikiLeaks to be prosecuted. After the release, the Obama administration said it was indeed pursuing a criminal investigation, Interpol revealed it has put out a call for Assange's arrest (ostensibly for his rape accusations), and Amazon booted WikiLeaks from its servers under pressure from U.S. Sen. Joe Lieberman, Synthroid For Sale.
WikiLeaks' actions left many journalists and media observers divided: An Economist blogger accused WikiLeaks of degenerating into gossip, and even Wikipedia co-founder Larry Sanger called them enemies of the American people. Assange and WikiLeaks had their defenders, purchase Synthroid, too: Slate's Jack Shafer praised them for puncturing "the prerogative of secrecy," and another Economist blogger made a similar argument. The Guardian's Simon Jenkins noted that "the job of the media is not to protect power from embarrassment." Meanwhile, Northeastern j-prof Dan Kennedy wrestled with the balance between transparency and secrecy.
Others' primary concern was not value judgments, but classification. Is WikiLeaks Synthroid For Sale, espionage. Journalism? Radically open government? Or, as CUNY j-prof C.W. Purchase Synthroid online, Anderson argued, is it a facilitator of real-time history documentation. NYU j-prof Jay Rosen hashed out his thoughts on WikiLeaks as a stateless news organization on video, concluding, "The watchdog press died, and what we have is WikiLeaks instead." Paul Balcerak wondered why WikiLeaks gets so much more attention than the press's own reporting.
If you really want to spend the weekend pondering the meaning of WikiLeaks, it's best to start with two posts: Some incisive questions by Salon's Dan Gillmor, and a brilliant post by Aaron Bady sifting through Assange's own words to determine his motivations behind WikiLeaks' radical transparency.
Rupert's big tablet splash: We've heard bits and pieces about Rupert Murdoch's planned tablet-based national news publication, but we got the first substantive report on the subject two weeks ago from Women's Wear Daily, Synthroid For Sale. Among the key details: It's going by The Daily, Synthroid price, coupon, it has a staff of 100, it'll cost 99 cents a week, and it'll come out once a day. The New York Observer gave us some more information about the publication's design (it's text-first and will be published overnight, but apparently looks pretty cool). Other tidbits: John Gruber at Daring Fireball heard that it'll pioneer a new app subscription API from Apple, and New York's Gabriel Snyder said it will have a centrist editorial outlook.
The reasons why this project is getting so much pre-launch attention seem pretty readily evident: Murdoch, Synthroid mg, original tablet news org, iPad news subscriptions, you know the rest. As The Columbia Journalism Review noted Synthroid For Sale, , what's new about this publication is that it won't even have a website. The initial response from the media-watching world was predominantly negative, with skepticism coming from The New York Times' David Carr, Gawker's Ryan Tate, Scott Rosenberg, Sam Diaz of ZDNet, GigaOM's Mathew Ingram, Fast Company's Kit Eaton, comprar en línea Synthroid, comprar Synthroid baratos, The Guardian's Emily Bell, and paidContent's Andrew Wallenstein.
Many of those critics made similar points, so here's a roundup of the main ones: 1) It's trying to impose slow print-think onto the speed-oriented world of mobile media (this is Rosenberg's main point); 2) The fact that it won't have inbound or outbound links means it can't share in the virality that makes news on the Web work; 3) The folks on board don't exactly seem like the tech revolutionaries they might need to be (Wallenstein's main point); and 4) How many people are actually going to pay for this, and can it really cover The Daily's costs. (Carr's main objection)
Several of those people also noted a few factors in Murdoch's favor: Carr argued that people will be more likely to pay for news in an app world than on the web, and both Tate and Eaton noted that Apple's Steve Jobs (who is reported to be tied to the project) is a pretty powerful guy with a history of success in ventures like these. We got a few good suggestions for Murdoch's project, Doses Synthroid work, too: TechCrunch's Erick Schonfeld said to make it local, real-time, and social; Frederic Filloux wanted it speedy, simple, beyond Apple, and with adjustable pricing; and at paidContent, Nic Newman wanted to see a mixture of free and paid content.
Designing apps for tablets and mobile media: Murdoch isn't the only one with a big new tablet app to unveil: Yahoo's Joe Pompeo summarized two others — mini-magazines called Nomad Editions and a new iPad magazine by Virgin called Project, Synthroid For Sale. Of those, Project, announced Tuesday, ordering Synthroid online, got a bit more attention. PaidContent had some details about its video cover and "living magazine" mindset, and All Things Digital's Peter Kafka pointed out the magazine's rather intimidating instruction page, though David Carr told NPR it's still pretty magazine-like.
Also in the process of launching: Next Issue Media, a joint venture by several magazine magnates, will launch its digital newsstand early next year and gave some details to MediaWeek, and Swedish publisher Bonnier, Synthroid photos, whose Mag+ everyone loved, is expanding into News+. Meanwhile, the Financial Times' iPad app is doing well, but The Guardian's Dan Sabbagh remained skeptical that most newspapers' iPad apps will be able to stand out among the sea of more enjoyable apps.
A couple more smart thoughts on mobile media: PaidContent founder Rafat Ali talked about Synthroid For Sale, designing for touchscreens, and Poynter's Damon Kiesow argued that smartphones are fundamentally a mobile device, while the iPad is a leisure device, so their apps can't be imposed onto each other: "To fully serve and engage an audience, an app needs to target one distinctive strength — either location or leisure — and make the content and experience fit that use."
Gawker grows beyond the blog: In advance of its coming overhaul early next year, Gawker head Nick Denton wrote a manifesto explaining why the network of sites is going beyond the blog format (his post at the previous link is in the sites' new design). Denton said he's discovered the new formula for online media success: Not so much Gawker's former trademark snarky meta-analysis, but a few huge juicy scoops accompanied by a steady stream of aggregation, all with a visual bent. He extended the model to include advertising and branding as well.
Reuters' Felix Salmon responded with a meticulous analysis of Gawker's new direction, Synthroid description, noting that while Denton was the first person to make blogging into "a large-scale commercial venture," he's now aggressively dumping blogging's defining reverse-chronological format. Ron Mwangaguhunga of eMedia Vitals compared Gawker's new model with a TV business model, and Anil Dash said that while Gawker is still a blog, it's borrowing Twitter's design that emphasizes both content and the stream of news. "By allowing that flow to continue regardless of which particular piece of embedded content has caught your eye, Gawker and Twitter are just showing the vibrancy and resilience of the format."
Why Twitter matters: Speaking of Twitter, Guardian editor Alan Rusbridger offered a stirring defense of Twitter's meaning for journalism as part of a lecture on the state of the Fourth Estate. His list of 15 reasons Twitter matters covers most everything: Reporting, conversation, aggregation, search, marketing, authority, writing, Synthroid For Sale. Likewise, Synthroid street price, GigaOM's Mathew Ingram argued that Twitter's real cultural power "could well be that it is the simplest, the easiest and arguably one of the most efficient forms of mass publishing — or at least micro-publishing — ever invented."
Later, Ingram took Twitter co-founder Biz Stone's apparently off-the-cuff statement that Twitter could develop a news network as an opportunity to think about how news orgs could filter Twitter into a usable crowdsourced newswire. And MediaBistro talked with Canada's National Post to get a sense of how one major newspaper uses Twitter.
Business-model developments and discussion: A few notes on the ever-evolving paid-content front: At least two more news organizations are using the Press+ system of Steve Brill's Journalism Online for their online revenue goals — ProPublica, which is using it to solicit donations online, and Oklahoma State's Daily O'Collegian, which will charge outside-the-area readers. Over at The Guardian, Cory Doctorow examined The Times of London's paywall numbers, and CrunchGear's Devin Coldewey thought out loud about a possible online paid-content system, order Synthroid from United States pharmacy.
Meanwhile, British journalist Kevin Anderson wrote a post arguing that value-added journalism has to be developed with specific revenue streams in mind. Howard Owens of The Batavian countered Synthroid For Sale, that would-be entrepreneurial journalists need to focus more on basic local events journalism than "adding value" or analytical journalism, and TBD's Steve Buttry tried to bring the two perspectives together.
Reading roundup: Here's what else you should see this week, in the quickest-hit form I can give it to you:
— A British court upheld a stipulation that news organizations can charge paid online news monitoring agencies for using their content. The Telegraph, TechCrunch Europe, and the Press Gazette explain why it's bad news for aggregators.
— No less an authority than World Wide Web inventor Tim Berners-Lee joined the chorus of people extolling the value of data journalism during a panel. A somewhat related debate broke out when Mark Luckie opined on the myths about digital journalism skills. Discount Synthroid, Journalist Andy Boyle disputed Luckie's claims about what new-media skills journalists need (and don't need) to know, and j-prof Mindy McAdams and journalist Brian Manzullo chimed in. Anthony DeBarros and Robert Hernandez turned the discussion toward data journalism, with Hernandez asserting that programming doesn't replace the story. That got Michelle Minkoff kind of riled up, Synthroid For Sale.
— The New York Times ran an article looking at the ways technology is creating increased distractions for young people, which was met by smart rebuttals by Duke prof Cathy Davidson and the Lab's own Megan Garber.
— Also at the Lab: USC prof Henry Jenkins on his concept of "spreadable" media.
— Mashable's Vadim Lavrusik wrote a great roundup of what's going on at the intersection of investigative journalism and social media.
— Finally, if you're looking for a single document to answer the question, "How should newspapers adapt to this new media environment?" you can't do much better than John Paton's presentation on how he's turned around the Journal Register Co. It's brilliant.
Similar posts: Cipro Price. Armour Dosage. Purchase Synthroid. Japan, craiglist, ebay, overseas, paypal. Buy Glucophage from mexico. Flagyl without prescription.
Trackbacks from: Synthroid For Sale. Synthroid For Sale. Synthroid For Sale. Buy generic Synthroid. Synthroid australia, uk, us, usa. Get Synthroid.
[This review was originally posted at the Nieman Journalism Lab Buy Lipitor No Prescription, on Nov. 12, 2010.]
Olbermann and objectivity: Another week, another journalist or pundit disciplined for violating a news organization's codes against appearances of bias: This week (actually, late last week) it was Keith Olbermann, liberal commentator for the liberal cable news channel MSNBC, suspended for donating money to Democratic congressional candidates, in violation of NBC News policy. Lipitor use, Olbermann issued an apology (though, as Forbes' Jeff Bercovici noted, it was laced with animus toward MSNBC), and returned to the air Tuesday. There were several pertinent peripheral bits to this story — Olbermann was reportedly suspended for his refusal to apologize on air, it's unclear whether NBC News' rules have actually applied to MSNBC, numerous other journalists have done just what Olbermann did — but that's the gist of it.
By now, we've all figured out what happens next: Scores of commentators weighed in on the appropriateness (or lack thereof) of Olbermann's suspension and NBC's ban on political contributions, Lipitor blogs. The primary arguments boiled down to the ones expressed by Poynter's Bob Steele and NYU's Jay Rosen in this Los Angeles Times piece: On one side, donating to candidates means journalists are acting as political activists, which corrodes their role as fair, independent reporters in the public interest, Buy Lipitor No Prescription. On the other, being transparent is a better way for journalists to establish trust with audiences than putting on a mask of objectivity.
Generally falling in the first camp are fellow MSNBC host Rachel Maddow ("We're a news operation. The rules around here are part of how you know that."), Northeastern j-prof Dan Kennedy (though he tempered his criticism of Olbermann in a second post), and The New York Times' David Carr ("Why merely annotate events when you can tilt the playing field?"). The Columbia Journalism Review was somewhere in the middle, Lipitor pics, saying Olbermann shouldn't be above the rules, but wondering if those rules need to change.
There were plenty of voices Buy Lipitor No Prescription, in the second camp, including the American Journalism Review's Rem Rieder, Michael Kinsley at Politico, and Lehigh j-prof Jeremy Littau all arguing for transparency.
Slate media critic Jack Shafer used the flap to urge MSNBC to let Olbermann and Maddow fly free as well-reported, openly partisan shows in the vein of respected liberal and conservative political journals. Jay Rosen took the opportunity to explain his pet phrase "The view from nowhere," which tweaks traditional journalism's efforts to "advertise the viewlessness of the news producer" as a means of gaining trust. He advocates transparency instead, and Terry Heaton provided statistics showing that the majority of young adults don't mind journalists' bias, as long as they're upfront about it.
On The Media's Brooke Gladstone summed up the issue well: "Ultimately, kjøpe Lipitor på nett, köpa Lipitor online, it’s the reporting that matters, reporting that is undistorted by attempts to appear objective, reporting that calls a lie a lie right after the lie, not in a box labeled “analysis,” reporting that doesn't distort truth by treating unequal arguments equally."
Commodify your paywall: We talked quite a bit last week about the new numbers on the paywall at Rupert Murdoch's Times of London, and new items in that discussion kept popping up this week. The Times released a few more details (flattering ones, Lipitor mg, naturally) about its post-paywall web audience. Among the most interesting figures is that the percentage of U.K.-based visitors to The Times' site has more than doubled since February, rising to 75 percent, Buy Lipitor No Prescription. Post-paywall visitors are also visiting the website more frequently and are more wealthier, according to News Corp.
Of course, the overall number of visitors is still way down, and the plan continued to draw heat. In a wide-ranging interview on Australian radio, Guardian editor Alan Rusbridger expressed surprise at the fact that The Times' print circulation dropped as their print-protectionist paywall went up. That, Lipitor dangers, he said, "suggests to me that we overlook the degree to which the digital forms of our journalism act as a kind of sort of marketing device for the newspapers." ResourceWebs' Evan Britton gave five reasons why news paywalls won't work, and Kachingle founder Cynthia Typaldos argued that future news paywalls will be tapping into a limited pool of people willing to pay for news on the web, squeezing each other out of the same small market.
Clay Shirky used The Times' paywall as a basis for some smart thoughts Buy Lipitor No Prescription, about why newspaper paywalls don't work in general. The Times' paywall represents old thinking, Shirky wrote (and the standard argument against it has been around just as long), but The Times' paywall feels differently because it's being taken as a "referendum on the future." Shirky said The Times is turning itself into a newsletter, Buy Lipitor without prescription, without making any fundamental modifications to its product or the basic economics of the web. "Paywalls do indeed help newspapers escape commodification, but only by ejecting the readers who think of the product as a commodity. This is, invariably, most of them," he wrote.
A conversation about blogging, voice, and ego: A singularly insightful conversation about blogging was sparked this week by Marc Ambinder, Lipitor canada, mexico, india, who wrote a thoughtful goodbye post at his long-running blog at The Atlantic. In it, Ambinder parsed out differences between good print journalism (ego-free, reliant on the unadorned facts for authority) and blogging (ego-intensive, requires the writer to inject himself into the narrative). With the switch from blogging to traditional reporting, Ambinder said, "I will no longer be compelled to turn every piece of prose into a personal, conclusive argument, to try and fit it into a coherent framework that belongs to a web-based personality called 'Marc Ambinder' that people read because it's 'Marc Ambinder,' rather than because it's good or interesting."
The folks at the fantastically written blog Snarkmarket used the post as a launching point for their own thoughts about the nature of blogging, Buy Lipitor No Prescription. Matt Thompson countered that Ambinder was reducing an incredibly diverse form into a single set of characteristics, taking particular exception to Ambinder's ego dichotomy. Lipitor dosage, Tim Carmody mused on blogging, voice, and authorship; and Robin Sloan defended Ambinder's decision to leave the "Thunderdome of criticism" that is political blogging. If you care at all about blogging or writing for the web in general, make sure to give all four posts a thorough read.
TBD's (possible) content/aggregation conflict: The new Washington-based local news site TBD has been very closely watchedsince it was launched in August, and it hit its first big bump in the road late last week, as founding general manager Jim Bradyresigned in quite a surprising move. In a memo Buy Lipitor No Prescription, to TBD employees, TBD owner Robert Allbritton (who also launched Politico) said Brady left because of "stylistic differences" with Allbritton. Despite the falling-out, Lipitor duration, Brady, a washingtonpost.com veteran, spoke highly of where TBD is headed in an email to staff and a few tweets.
But the immediate questions centered on the nature of those differences between Allbritton and Brady. FishbowlDC reported and Business Insider's Henry Blodget inferred from Allbritton's memo that the conflict came down to an original-content-centric model (Allbritton) and a more aggregation-based model (Brady). Brady declared his affirmation of both pieces — he told Poynter's Steve Myers he's pro-original content and the conflict wasn't old media/new media, but didn't go into many more details — but that didn't keep Blodget from taking the aggregation side: The web, My Lipitor experience, he said, "has turned aggregation into a form of content--and a very valuable one at that." Lost Remote's Cory Bergman, meanwhile, noted that while creating content is expensive, Allbritton's made the necessary investments and made it profitable before with Politico.
A new iPad app and competitor: There were two substantive pieces of tablet-related news this week: First, The Washington Post released its iPad app, accompanying its launch with a fun ad most everyone seemed to enjoy, Buy Lipitor No Prescription. Poynter's Damon Kiesow wrote a quick summary of the app, which got a decent review from The Post's Rob Pegoraro. For you design geeks, Sarah Sampsel wrote two good posts about the app design process, Lipitor over the counter.
The other tablet tidbit was the release of Samsung's Galaxy Tab, which runs on Google's Android system. Kiesow rounded up a few of the initial reviews from All Things Digital (a real iPad competitor, though the iPad is better), The New York Times (beautiful with some frustrations), Wired (more convenient than the iPad, but has stability problems) and Gizmodo ("a grab bag of neglect, Lipitor from mexico, good intentions and poor execution"). Buy Lipitor No Prescription, Kiesow also added a few initial impressions of the Galaxy's implications for publishers, predicting that as it takes off, it will put pressure on publishers to move to HTML5 mobile websites, rather than developing native apps.
In other tablet news, MediaWeek looked at the excitement the iPad is generating within the media industry, but ESPN exec John Skipper isn't buying the hype, telling MarketWatch's Jon Friedman, "Whenever a new platform comes up, people want to take the old platform and transport it to the new platform." It didn't work on the Internet, Skipper said, it won't work on the iPad either, generic Lipitor.
Reading roundup: More thoughtful stuff about news and the web was written this week than most normal people have time to get to. Here's a sample:
— First, a piece of news: U.S. News & World Report announced last week that it's dropping its regular print edition and going essentially online-only, only printing single-topic special issues for newsstand sales. The best analysis on the move was at Advertising Age, Buy Lipitor No Prescription.
— Two great pieces on journalism's collaborative future: Guardian editor Alan Rusbridger in essay form, and UBC j-prof Alfred Hermida in audio and slide form. Where can i buy cheapest Lipitor online, — Poynter published an essay by NYU professor Clay Shirky on "the shock of inclusion" in journalism and the obsolescence of the term "consumer." Techdirt's Mike Masnick added a few quick thoughts of his own.
— Two cool posts on data journalism — an overview on its rise by The Columbia Journalism Review's Lauren Kirchner, and a list of great tools by Michelle Minkoff.
— Finally, two long thinkpieces on Facebook that, quite honestly, I haven't gotten to read yet — one by Zadie Smith at The New York Review of Books, and the other by The Atlantic's Alexis Madrigal. I'm going to spend some time with them this weekend, and I have a feeling you probably should, too.
Similar posts: Order Cephalexin. Buy Zoloft No Prescription. Tramadol Cost. Armour for sale. Where can i buy Cephalexin online. Synthroid without prescription.
Trackbacks from: Buy Lipitor No Prescription. Buy Lipitor No Prescription. Buy Lipitor No Prescription. After Lipitor. Buy Lipitor from canada. Order Lipitor no prescription.